US 10434174
Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells
granted A61KA61K2039/505A61K31/282
Quick answer
US patent 10434174 (Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K2039/505, A61K31/282, A61K31/555, A61K33/243